AbbVie Rg
ABBV
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
12/27/2024 - 16:15:00
Bid
12/27/2024 - 15:59:59
Bid
Volume
Ask
12/27/2024 - 15:59:59
Ask
Volume
178.01
-1.19 ( -0.66% )
178.07
17,300
178.08
7,600
More information
Analysis by TheScreener
24.12.2024
Evaluation Slightly positive  
Interest Strong  
Sensibility Low  
Analysis date: 24.12.2024
Global Evaluation
  Slightly positive
The stock is classified in the slightly positive zone since 11.10.2024.
Interest
  Strong
Strong interest since 17.12.2024.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 26.11.2024 at a price of 181.14.
Evaluation
  Strongly undervalued
 
Based on its growth potential and our own criteria, at its current price the stock is strongly undervalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 12.11.2024), the stock traded below its moving average. The confirmed Technical Reverse (Tech Reverse + 1.75%) point is .
4wk Rel Perf
  0.78%
 
The four week relative performance versus SP500 is .
Sensibility
  Low
Low, no change over 1 year.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.87%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.26%.
Mkt Cap in $bn
  315.24
With a market capitalization >$8bn, ABBVIE is considered a large-cap stock.
G/PE Ratio
  1.30
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  11.68
The estimated PE is for the year 2027.
LT Growth
  11.59%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  22
Over the last seven weeks, an average of 22 analysts provided earnings per share estimates.
Dividend Yield
  3.61%
The twelve month estimated dividend yield represents 42.22% of earnings forecasts.
Beta
  10
For 1% of index variation, the stock varies on average by 0.10%.
Correlation
  0.05
Stock movements are totally independent of index variations.
Value at Risk
  14.30
The value at risk is estimated at USD 14.30. The risk is therefore 7.95%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  05.04.2013